MGMT and central nervous system cancer: Previous studies on glioma have revealed many molecular markers, such as IDH, 1p19q, MGMT, sarcomarcoma proto oncogene B, telomerase reverse transcriptase tert, and epidermal growth factor receptor [5–7].